Literature DB >> 11796742

Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain.

Elvira Alvarez1, Isabel Roncero, Julie A Chowen, Patricia Vázquez, Enrique Blázquez.   

Abstract

Our previous description of functional glucokinase isoforms in the rat brain has opened new questions concerning the presence of glucokinase regulatory protein in the brain and the functional role of its interactions with glucokinase. In this study, we found glucokinase regulatory protein mRNA in rat brain, pancreatic islets and liver. In addition, we found two other variant splicing isoforms, both identified in hypothalamus, pancreatic islets and liver. In situ hybridization studies revealed the presence of glucokinase regulatory protein mRNA, the highest number of positive cells being found in the paraventricular nucleus of the hypothalamus. Glucokinase regulatory protein gene expression gave rise to a protein of 69 kDa mainly in nuclear and soluble cell fractions. Glutathione S-transferase protein fused either to rat liver or human pancreatic islet glucokinase were able to precipitate glucokinase regulatory protein from liver or hypothalamic extracts in the presence of fructose-6-phosphate, the amount of protein co-precipitated being decreased with fructose-1-phosphate. These findings suggest that the presence of glucokinase and glucokinase regulatory protein in the rat brain would facilitate the adaptation of this organ to fluctuations in blood glucose concentrations, and both proteins may participate in glucose-sensing and metabolic regulation in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796742     DOI: 10.1046/j.0022-3042.2001.00677.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

1.  Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour.

Authors:  Verónica Hurtado-Carneiro; Carmen Sanz; Isabel Roncero; Patricia Vazquez; Enrique Blazquez; Elvira Alvarez
Journal:  Mol Neurobiol       Date:  2012-02-05       Impact factor: 5.590

2.  Decreased glucokinase protein expression in the aged gerbil hippocampus.

Authors:  Choong Hyun Lee; Joon Ha Park; Moo-Ho Won
Journal:  Cell Mol Neurobiol       Date:  2013-03-21       Impact factor: 5.046

3.  Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.

Authors:  María Galán; Olivier Vincent; Isabel Roncero; Sharona Azriel; Pedro Boix-Pallares; Elías Delgado-Alvarez; Francisco Díaz-Cadórniga; Enrique Blázquez; María-Angeles Navas
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

4.  Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.

Authors:  C M García-Herrero; M Galán; O Vincent; B Flández; M Gargallo; E Delgado-Alvarez; E Blázquez; M A Navas
Journal:  Diabetologia       Date:  2006-12-21       Impact factor: 10.122

5.  Genetic variation of habitual coffee consumption and glycemic changes in response to weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial.

Authors:  Liyuan Han; Wenjie Ma; Dianjianyi Sun; Yoriko Heianza; Tiange Wang; Yan Zheng; Tao Huang; Donghui Duan; J George A Bray; Catherine M Champagne; Frank M Sacks; Lu Qi
Journal:  Am J Clin Nutr       Date:  2017-09-20       Impact factor: 7.045

6.  Glial glucokinase expression in adult and post-natal development of the hypothalamic region.

Authors:  Carola Millán; Fernando Martínez; Christian Cortés-Campos; Isabel Lizama; Maria Jose Yañez; Paula Llanos; Karin Reinicke; Federico Rodríguez; Bruno Peruzzo; Francisco Nualart; Maria Angeles García
Journal:  ASN Neuro       Date:  2010-05-25       Impact factor: 4.146

7.  Time-course changes in immunoreactivities of glucokinase and glucokinase regulatory protein in the gerbil hippocampus following transient cerebral ischemia.

Authors:  Joon Ha Park; Choong Hyun Lee; In Hye Kim; Ji Hyeon Ahn; Jeong-Hwi Cho; Bing Chun Yan; Jae-Chul Lee; Tae Hun Lee; Jeong Yeol Seo; Jun Hwi Cho; Moo-Ho Won; Il-Jun Kang
Journal:  Neurochem Res       Date:  2013-10-22       Impact factor: 3.996

8.  Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population.

Authors:  Q Qi; Y Wu; H Li; R J F Loos; F B Hu; L Sun; L Lu; A Pan; C Liu; H Wu; L Chen; Z Yu; X Lin
Journal:  Diabetologia       Date:  2009-02-25       Impact factor: 10.122

9.  Impact of recurring intermediate insulin-induced hypoglycemia on hypothalamic paraventricular corticotropin-releasing hormone, oxytocin, vasopressin and glucokinase gene profiles: role of type II glucocorticoid receptors.

Authors:  Karen P Briski; Ajay Y Kale; Kamlesh V Vavaiya
Journal:  Exp Brain Res       Date:  2009-05-06       Impact factor: 1.972

10.  The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.

Authors:  Nicola L Beer; Nicholas D Tribble; Laura J McCulloch; Charlotta Roos; Paul R V Johnson; Marju Orho-Melander; Anna L Gloyn
Journal:  Hum Mol Genet       Date:  2009-07-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.